NYSE · CIK 0000944695
THG HANOVER INSURANCE GROUP, INC.
Insider trading from SEC Form 4. Last filing 14 d ago. Close $219.33 on Oct 9, 2026, +33% from the 52-week low and -6% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
20
with a Form 4 at this company
Price and insider trades, last year
THGOct 9, 2026 · close 219.33
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at HANOVER INSURANCE GROUP, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | Jane D Carlin director sell | $164k 977 shares | -100% | +19% from low-4% from high | |
| 15Weak | Bryan J Salvatore Executive Vice President sell | $1.8M 10,526 shares | -29% | +18% from low-5% from high | |
| 15Weak | John C Roche President and CEO sell | $1.6M 8,906 shares | -7% | +23% from low0% from high | |
| 0Weak | John C Roche President and CEO sell | $123k 701 shares | -1% | +22% from low-1% from high | |
| 2Weak | John C Roche President and CEO sell | $193k 1,100 shares | -1% | +22% from low0% from high | |
| 23Weak | John C Roche President and CEO sell | $1.8M 10,706 shares | -8% | - | |
| 23Weak | Bryan J Salvatore Executive Vice President sell | $1.8M 10,526 shares | -29% | - | |
| 33Weak | Jeffrey M Farber Executive Vice President sell | $1.2M 6,987 shares | -14% | - | |
| 10Weak | Jeffrey M Farber Executive Vice President sell | $17k 100 shares | -0% | - | |
| 32Weak | Jeffrey M Farber Executive Vice President sell | $811k 4,913 shares | -9% | - | |
| 54Moderate | Denise Lowsley Executive Vice President sell | $296k 1,823 shares | -31% | - | |
| 38Weak | Warren E. Barnes SVP & Princpl. Accntg. Officer sell | $226k 1,392 shares | -32% | - | |
| 40Moderate | Jeffrey M Farber Executive Vice President sell | $1.9M 12,000 shares | -18% | - | |
| 25Weak | Jeffrey M Farber Executive Vice President sell | $1.9M 12,000 shares | -15% | - | |
| 11Weak | Jeffrey M Farber Executive Vice President sell | $407k 2,699 shares | -3% | - | |
| 16Weak | Jeffrey M Farber Executive Vice President sell | $745k 4,951 shares | -6% | - |
Congressional trades
1 trade in THG disclosed by members of Congress under the STOCK Act. All congressional trades.
- Jefferson ShreveHouse · R-IN · last Jun 22, 20250 bought
1 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Jefferson Shreve House · R-IN | Sale | THG Hanover Insurance Group Inc | $15k to $50k | May 12, 2025 / Jun 22, 2025 41 days after the trade | Clerk |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | Dennis Francis Kerrigan Executive Vice President | AGrant or award Common Stock | +15 | $0.00 | $0 | 12,018 | 14 d ago |
| Sep 25, 2026 | John C Roche President and CEO | AGrant or award Common Stock | +120 | $0.00 | $0 | 141,253 | 14 d ago |
| Sep 25, 2026 | Richard W Lavey Executive Vice President | AGrant or award Common Stock | +28 | $0.00 | $0 | 34,475 | 14 d ago |
| Sep 25, 2026 | Jeffrey M Farber Executive Vice President | AGrant or award Common Stock | +42 | $0.00 | $0 | 68,819 | 14 d ago |
| Sep 25, 2026 | Theodore H Bunting JR director | AGrant or award Common Stock | +4 | $0.00 | $0 | 5,838 | 14 d ago |
| Sep 25, 2026 | Patricia A. Norton-Gatto SVP & Princpl. Accntg. Officer | AGrant or award Common Stock | +6 | $0.00 | $0 | 2,452 | 14 d ago |
| Sep 25, 2026 | Kevin Bradicich director | AGrant or award Common Stock | +4 | $0.00 | $0 | 10,099 | 14 d ago |
| Sep 25, 2026 | Kathy S Lane director | AGrant or award Common Stock | +4 | $0.00 | $0 | 2,776 | 14 d ago |
| Sep 25, 2026 | William E. Donnell director | AGrant or award Common Stock | +4 | $0.00 | $0 | 850 | 14 d ago |
| Sep 25, 2026 | Francisco Aristeguieta director | AGrant or award Common Stock | +4 | $0.00 | $0 | 4,060 | 14 d ago |
| Sep 25, 2026 | Jane D Carlin director | AGrant or award Common Stock | +4 | $0.00 | $0 | 2,273 | 14 d ago |
| Sep 25, 2026 | David John Lovely Executive Vice President | AGrant or award Common Stock | +10 | $0.00 | $0 | 3,829 | 14 d ago |
| Sep 25, 2026 | J Paul Condrin director | AGrant or award Common Stock | +4 | $0.00 | $0 | 6,359 | 14 d ago |
| Sep 25, 2026 | Joseph R Ramrath director | AGrant or award Common Stock | +4 | $0.00 | $0 | 33,837 | 14 d ago |
| Sep 25, 2026 | Elizabeth A Ward director | AGrant or award Common Stock | +4 | $0.00 | $0 | 5,886 | 14 d ago |
| Sep 25, 2026 | Willard T Lee Executive Vice President | AGrant or award Common Stock | +11 | $0.00 | $0 | 6,004 | 14 d ago |
| Sep 25, 2026 | Cynthia Egan director | AGrant or award Common Stock | +4 | $0.00 | $0 | 10,209 | 14 d ago |
| Sep 25, 2026 | Bryan J Salvatore Executive Vice President | AGrant or award Common Stock | +24 | $0.00 | $0 | 29,118 | 14 d ago |
| Jun 27, 2025 | Jeffrey M Farber Executive Vice President | AGrant or award Common Stock | +52 | $0.00 | $0 | 45,943 | Jun 30, 2025 |
| Jun 27, 2025 | Richard W Lavey Executive Vice President | AGrant or award Common Stock | +33 | $0.00 | $0 | 39,112 | Jun 30, 2025 |
| Jun 27, 2025 | Dennis Francis Kerrigan Executive Vice President | AGrant or award Common Stock | +19 | $0.00 | $0 | 10,014 | Jun 30, 2025 |
| Jun 27, 2025 | David John Lovely Executive Vice President | AGrant or award Common Stock | +12 | $0.00 | $0 | 2,266 | Jun 30, 2025 |
| Jun 27, 2025 | Denise Lowsley Executive Vice President | AGrant or award Common Stock | +12 | $0.00 | $0 | 5,046 | Jun 30, 2025 |
| Jun 27, 2025 | Willard T Lee Executive Vice President | AGrant or award Common Stock | +13 | $0.00 | $0 | 5,468 | Jun 30, 2025 |
| Jun 27, 2025 | Bryan J Salvatore Executive Vice President | AGrant or award Common Stock | +29 | $0.00 | $0 | 25,893 | Jun 30, 2025 |
| Jun 27, 2025 | John C Roche President and CEO | AGrant or award Common Stock | +141 | $0.00 | $0 | 124,554 | Jun 30, 2025 |
| May 23, 2025 | Jane D Carlin director | SOpen-market sale Common Stock | -977 | $167.81 | $164k | 0 | May 23, 2025 |
| May 14, 2025 | J Paul Condrin director | AGrant or award Common Stock | +977 | $0.00 | $0 | 5,509 | May 15, 2025 |
| May 14, 2025 | William E. Donnell director | AGrant or award Common Stockindirect: Deferral Agreement | +977 | $0.00 | $0 | 977 | May 15, 2025 |
| May 14, 2025 | Cynthia Egan director | AGrant or award Common Stockindirect: Deferral Agreement | +977 | $0.00 | $0 | 977 | May 15, 2025 |
| May 14, 2025 | Kathy S Lane director | AGrant or award Common Stockindirect: Deferral Agreement | +977 | $0.00 | $0 | 4,829 | May 15, 2025 |
| May 14, 2025 | Joseph R Ramrath director | AGrant or award Common Stock | +977 | $0.00 | $0 | 32,987 | May 15, 2025 |
| May 14, 2025 | Elizabeth A Ward director | AGrant or award Common Stock | +977 | $0.00 | $0 | 5,036 | May 15, 2025 |
| May 14, 2025 | Francisco Aristeguieta director | AGrant or award Common Stock | +977 | $0.00 | $0 | 4,210 | May 15, 2025 |
| May 14, 2025 | Kevin Bradicich director | AGrant or award Common Stock | +977 | $0.00 | $0 | 9,249 | May 15, 2025 |
| May 14, 2025 | Theodore H Bunting JR director | AGrant or award Common Stock | +977 | $0.00 | $0 | 6,188 | May 15, 2025 |
| May 14, 2025 | Jane D Carlin director | AGrant or award Common Stock | +977 | $0.00 | $0 | 977 | May 15, 2025 |
| May 7, 2025 | Bryan J Salvatore Executive Vice President | MOption exercise Common Stock10b5-1 | +10,526 | $82.39 | $867k | 36,390 | May 8, 2025 |
| May 7, 2025 | Bryan J Salvatore Executive Vice President | SOpen-market sale Common Stock10b5-1 | -4,975 | $166.12 | $826k | 31,415 | May 8, 2025 |
| May 7, 2025 | Bryan J Salvatore Executive Vice President | SOpen-market sale Common Stock10b5-1 | -5,437 | $167.01 | $908k | 25,978 | May 8, 2025 |
| May 7, 2025 | Bryan J Salvatore Executive Vice President | SOpen-market sale Common Stock10b5-1 | -114 | $167.76 | $19k | 25,864 | May 8, 2025 |
| May 7, 2025 | Bryan J Salvatore Executive Vice President | MOption exercise Common Stock Option (right to buy)derivative10b5-1 | -10,526 | $0.00 | $0 | 0 | May 8, 2025 |
| Apr 1, 2025 | John C Roche President and CEO | MOption exercise Common Stock10b5-1 | +8,906 | $77.91 | $694k | 133,320 | Apr 2, 2025 |
| Apr 1, 2025 | John C Roche President and CEO | SOpen-market sale Common Stock10b5-1 | -8,906 | $175.17 | $1.6M | 124,414 | Apr 2, 2025 |
| Apr 1, 2025 | John C Roche President and CEO | MOption exercise Common Stock Option (right to buy)derivative10b5-1 | -8,906 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 28, 2025 | John C Roche President and CEO | MOption exercise Common Stock10b5-1 | +400 | $77.91 | $31k | 124,678 | Apr 1, 2025 |
| Mar 28, 2025 | Jeffrey M Farber Executive Vice President | AGrant or award Common Stock | +50 | $0.00 | $0 | 45,891 | Apr 1, 2025 |
| Mar 28, 2025 | Bryan J Salvatore Executive Vice President | AGrant or award Common Stock | +28 | $0.00 | $0 | 25,864 | Apr 1, 2025 |
| Mar 28, 2025 | Dennis Francis Kerrigan Executive Vice President | AGrant or award Common Stock | +18 | $0.00 | $0 | 9,996 | Apr 1, 2025 |
| Mar 28, 2025 | Richard W Lavey Executive Vice President | AGrant or award Common Stock | +31 | $0.00 | $0 | 39,079 | Apr 1, 2025 |
| Mar 28, 2025 | Willard T Lee Executive Vice President | AGrant or award Common Stock | +12 | $0.00 | $0 | 5,455 | Apr 1, 2025 |
| Mar 28, 2025 | Denise Lowsley Executive Vice President | AGrant or award Common Stock | +12 | $0.00 | $0 | 5,034 | Apr 1, 2025 |
| Mar 28, 2025 | David John Lovely Executive Vice President | AGrant or award Common Stock | +12 | $0.00 | $0 | 2,254 | Apr 1, 2025 |
| Mar 28, 2025 | John C Roche President and CEO | SOpen-market sale Common Stock10b5-1 | -400 | $175.03 | $70k | 124,278 | Apr 1, 2025 |
| Mar 28, 2025 | John C Roche President and CEO | AGrant or award Common Stock10b5-1 | +136 | $0.00 | $0 | 124,414 | Apr 1, 2025 |
| Mar 31, 2025 | John C Roche President and CEO | MOption exercise Common Stock10b5-1 | +301 | $77.91 | $23k | 124,715 | Apr 1, 2025 |
| Mar 31, 2025 | John C Roche President and CEO | SOpen-market sale Common Stock10b5-1 | -301 | $175.00 | $53k | 124,414 | Apr 1, 2025 |
| Mar 28, 2025 | John C Roche President and CEO | MOption exercise Common Stock Option (right to buy)derivative10b5-1 | -400 | $0.00 | $0 | 9,207 | Apr 1, 2025 |
| Mar 31, 2025 | John C Roche President and CEO | MOption exercise Common Stock Option (right to buy)derivative10b5-1 | -301 | $0.00 | $0 | 8,906 | Apr 1, 2025 |
| Mar 26, 2025 | John C Roche President and CEO | MOption exercise Common Stock10b5-1 | +900 | $77.91 | $70k | 125,178 | Mar 28, 2025 |
| Mar 26, 2025 | John C Roche President and CEO | SOpen-market sale Common Stock10b5-1 | -900 | $175.17 | $158k | 124,278 | Mar 28, 2025 |
| Mar 27, 2025 | John C Roche President and CEO | MOption exercise Common Stock10b5-1 | +200 | $77.91 | $16k | 124,478 | Mar 28, 2025 |
| Mar 27, 2025 | John C Roche President and CEO | SOpen-market sale Common Stock10b5-1 | -200 | $175.01 | $35k | 124,278 | Mar 28, 2025 |
| Mar 26, 2025 | John C Roche President and CEO | MOption exercise Common Stock Option (right to buy)derivative10b5-1 | -900 | $0.00 | $0 | 9,807 | Mar 28, 2025 |
| Mar 27, 2025 | John C Roche President and CEO | MOption exercise Common Stock Option (right to buy)derivative10b5-1 | -200 | $0.00 | $0 | 9,607 | Mar 28, 2025 |
| Mar 3, 2025 | John C Roche President and CEO | MOption exercise Common Stock10b5-1 | +10,706 | $77.91 | $834k | 134,984 | Mar 4, 2025 |
| Mar 3, 2025 | Bryan J Salvatore Executive Vice President | MOption exercise Common Stock10b5-1 | +10,526 | $82.39 | $867k | 36,362 | Mar 4, 2025 |
| Mar 3, 2025 | John C Roche President and CEO | SOpen-market sale Common Stock10b5-1 | -1,894 | $170.91 | $324k | 133,090 | Mar 4, 2025 |
| Mar 3, 2025 | Bryan J Salvatore Executive Vice President | SOpen-market sale Common Stock10b5-1 | -1,500 | $170.83 | $256k | 34,862 | Mar 4, 2025 |
| Mar 3, 2025 | John C Roche President and CEO | SOpen-market sale Common Stock10b5-1 | -3,303 | $171.86 | $568k | 129,787 | Mar 4, 2025 |
| Mar 3, 2025 | Bryan J Salvatore Executive Vice President | SOpen-market sale Common Stock10b5-1 | -3,992 | $171.86 | $686k | 30,870 | Mar 4, 2025 |
| Mar 3, 2025 | John C Roche President and CEO | SOpen-market sale Common Stock10b5-1 | -5,509 | $172.66 | $951k | 124,278 | Mar 4, 2025 |
| Mar 3, 2025 | Bryan J Salvatore Executive Vice President | SOpen-market sale Common Stock10b5-1 | -5,034 | $172.67 | $869k | 25,836 | Mar 4, 2025 |
| Mar 3, 2025 | John C Roche President and CEO | MOption exercise Common Stock Option (right to buy)derivative10b5-1 | -10,706 | $0.00 | $0 | 10,707 | Mar 4, 2025 |
| Mar 3, 2025 | Bryan J Salvatore Executive Vice President | MOption exercise Common Stock Option (right to buy)derivative10b5-1 | -10,526 | $0.00 | $0 | 10,526 | Mar 4, 2025 |
| Feb 28, 2025 | Jeffrey M Farber Executive Vice President | FTax withholding Common Stock | -3,682 | $170.53 | $628k | 45,841 | Mar 3, 2025 |
| Feb 28, 2025 | Dennis Francis Kerrigan Executive Vice President | FTax withholding Common Stock | -1,180 | $170.53 | $201k | 9,978 | Mar 3, 2025 |
| Feb 28, 2025 | Richard W Lavey Executive Vice President | FTax withholding Common Stock | -1,917 | $170.53 | $327k | 39,048 | Mar 3, 2025 |
| Feb 28, 2025 | Bryan J Salvatore Executive Vice President | FTax withholding Common Stock | -1,836 | $170.53 | $313k | 25,836 | Mar 3, 2025 |
| Feb 28, 2025 | Willard T Lee Executive Vice President | FTax withholding Common Stock | -770 | $170.53 | $131k | 5,443 | Mar 3, 2025 |
| Feb 28, 2025 | Denise Lowsley Executive Vice President | FTax withholding Common Stock | -832 | $170.53 | $142k | 5,022 | Mar 3, 2025 |
| Feb 27, 2025 | John C Roche President and CEO | MOption exercise Common Stock | +22,943 | $66.14 | $1.5M | 148,707 | Mar 3, 2025 |
| Feb 27, 2025 | John C Roche President and CEO | FTax withholding Common Stock | -15,604 | $166.00 | $2.6M | 133,103 | Mar 3, 2025 |
| Feb 28, 2025 | John C Roche President and CEO | FTax withholding Common Stock | -8,826 | $170.53 | $1.5M | 124,278 | Mar 3, 2025 |
| Feb 27, 2025 | John C Roche President and CEO | MOption exercise Common Stock Option (right to buy)derivative | +22,943 | $0.00 | $0 | 0 | Mar 3, 2025 |
| Feb 24, 2025 | Dennis Francis Kerrigan Executive Vice President | AGrant or award Common Stock | +1,328 | $0.00 | $0 | 9,832 | Feb 26, 2025 |
| Feb 24, 2025 | John C Roche President and CEO | AGrant or award Common Stock | +9,554 | $0.00 | $0 | 115,368 | Feb 26, 2025 |
| Feb 24, 2025 | Warren E. Barnes SVP & Princpl. Accntg. Officer | AGrant or award Common Stock | +212 | $0.00 | $0 | 3,226 | Feb 26, 2025 |
| Feb 25, 2025 | David John Lovely Executive Vice President | AGrant or award Common Stock | +773 | $0.00 | $0 | 2,242 | Feb 26, 2025 |
| Feb 24, 2025 | Bryan J Salvatore Executive Vice President | AGrant or award Common Stock | +1,931 | $0.00 | $0 | 25,541 | Feb 26, 2025 |
| Feb 24, 2025 | Denise Lowsley Executive Vice President | AGrant or award Common Stock | +905 | $0.00 | $0 | 4,992 | Feb 26, 2025 |
| Feb 24, 2025 | Jeffrey M Farber Executive Vice President | AGrant or award Common Stock | +3,981 | $0.00 | $0 | 45,705 | Feb 26, 2025 |
| Feb 24, 2025 | Willard T Lee Executive Vice President | AGrant or award Common Stock | +846 | $0.00 | $0 | 5,284 | Feb 26, 2025 |
| Feb 24, 2025 | Richard W Lavey Executive Vice President | AGrant or award Common Stock | +2,172 | $0.00 | $0 | 38,519 | Feb 26, 2025 |
| Feb 25, 2025 | David John Lovely Executive Vice President | AGrant or award Common Stock Option (right to buy)derivative | +3,539 | $0.00 | $0 | 3,539 | Feb 26, 2025 |
| Feb 24, 2025 | Bryan J Salvatore Executive Vice President | AGrant or award Common Stock | +353 | $0.00 | $0 | 25,894 | Feb 26, 2025 |
| Feb 24, 2025 | Dennis Francis Kerrigan Executive Vice President | AGrant or award Common Stock | +243 | $0.00 | $0 | 10,075 | Feb 26, 2025 |
| Feb 24, 2025 | John C Roche President and CEO | AGrant or award Common Stock | +1,744 | $0.00 | $0 | 117,112 | Feb 26, 2025 |
| Feb 24, 2025 | Denise Lowsley Executive Vice President | AGrant or award Common Stock | +166 | $0.00 | $0 | 5,158 | Feb 26, 2025 |
| Feb 24, 2025 | Jeffrey M Farber Executive Vice President | AGrant or award Common Stock | +727 | $0.00 | $0 | 46,432 | Feb 26, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Francisco Aristeguietadirector
- Warren E. BarnesSVP & Princpl. Accntg. Officer
- Kevin Bradicichdirector
- Theodore H Bunting JRdirector
- Jane D Carlindirector
- J Paul Condrindirector
- William E. Donnelldirector
- Cynthia Egandirector
- Jeffrey M FarberExecutive Vice President
- Dennis Francis KerriganExecutive Vice President
- Kathy S Lanedirector
- Richard W LaveyExecutive Vice President
- David John LovelyExecutive Vice President
- Willard T LeeExecutive Vice President
- Denise LowsleyExecutive Vice President
- Patricia A. Norton-GattoSVP & Princpl. Accntg. Officer
- Joseph R Ramrathdirector
- John C RochePresident and CEO
- Bryan J SalvatoreExecutive Vice President
- Elizabeth A Warddirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.